Literature DB >> 18374518

Baclofen attenuates cue-induced reinstatement of alcohol-seeking behavior in Sardinian alcohol-preferring (sP) rats.

Paola Maccioni1, Przemyslaw Bienkowski, Mauro A M Carai, Gian Luigi Gessa, Giancarlo Colombo.   

Abstract

The GABA(B) receptor agonist, baclofen, suppressed alcohol deprivation effect (a proposed experimental model of alcohol relapse) in Sardinian alcohol-preferring rats. The present study was designed to extend the characterization of the "anti-relapse" properties of baclofen to the reinstatement of alcohol-seeking behavior (another proposed model of alcohol relapse). Rats of the sP line were first trained to lever press for alcohol under a fixed ratio 4 schedule of reinforcement. Subsequently, rats were exposed to two within-session 70-min extinction/reinstatement tests with saline or baclofen administered in a counterbalanced, within-subject design. After a 60-min extinction phase, an alcohol-associated stimulus complex was presented (reinstatement phase). Saline or baclofen (3 mg/kg) were administered via a permanent intraperitoneal catheter, 30 min before the reinstatement phase. During the reinstatement phase, baclofen administration: (a) reduced by approximately 60% responses on the previously active lever, (b) increased latency to the first response and (c) decreased the response rate. These results indicate that baclofen reduced cue-induced reinstatement of alcohol-seeking behavior in sP rats.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18374518     DOI: 10.1016/j.drugalcdep.2008.02.006

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  27 in total

Review 1.  Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.

Authors:  Megan M Yardley; Lara A Ray
Journal:  Addict Biol       Date:  2016-02-01       Impact factor: 4.280

2.  Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1.

Authors:  David J Hinton; Moonnoh R Lee; Taylor L Jacobson; Prasanna K Mishra; Mark A Frye; David A Mrazek; Slobodan I Macura; Doo-Sup Choi
Journal:  Neuropharmacology       Date:  2012-06       Impact factor: 5.250

Review 3.  Rat animal models for screening medications to treat alcohol use disorders.

Authors:  Richard L Bell; Sheketha R Hauser; Tiebing Liang; Youssef Sari; Antoniette Maldonado-Devincci; Zachary A Rodd
Journal:  Neuropharmacology       Date:  2017-02-16       Impact factor: 5.250

4.  The Potent Effect of Environmental Context on Relapse to Alcohol-Seeking After Extinction.

Authors:  Patricia H Janak; Nadia Chaudhri
Journal:  Open Addict J       Date:  2010-01-01

5.  Baclofen effects on alcohol seeking, self-administration and extinction of seeking responses in a within-session design in baboons.

Authors:  Angela N Duke; Barbara J Kaminski; Elise M Weerts
Journal:  Addict Biol       Date:  2012-03-28       Impact factor: 4.280

6.  Assessment of GABA-B, metabotropic glutamate, and opioid receptor involvement in an animal model of binge drinking.

Authors:  Michelle A Tanchuck; Naomi Yoneyama; Matthew M Ford; Andrea M Fretwell; Deborah A Finn
Journal:  Alcohol       Date:  2010-09-16       Impact factor: 2.405

Review 7.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

Review 8.  How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective.

Authors:  Peter Clapp; Sanjiv V Bhave; Paula L Hoffman
Journal:  Alcohol Res Health       Date:  2008

9.  Acute interaction of baclofen in combination with alcohol in heavy social drinkers.

Authors:  Suzette M Evans; Adam Bisaga
Journal:  Alcohol Clin Exp Res       Date:  2008-10-06       Impact factor: 3.455

Review 10.  Development of pharmacotherapies for drug addiction: a Rosetta stone approach.

Authors:  George F Koob; G Kenneth Lloyd; Barbara J Mason
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.